Fenwick represented Amyris, Inc. (NASDAQ: AMRS), the industrial bioscience company, in its registered offering, pursuant to an effective shelf registration statement previously filed with the SEC, of 22,140 Series A Preferred stock and a concurrent private placement where it sold 65,203 shares of Series B Preferred Stock and issued warrants for the purchase of its common stock.
Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the exclusive placement agent for the offerings.
The Fenwick transaction team included corporate partners Gordon Davidson, David Michaels and Daniel Winnike and corporate associates Faisal Rashid, Priscila Bastazin and Travis Robertson.